Immunotherapy trial eligibility criteria exclude majority of metastatic melanoma patientsmedwireNewsmedwireNews: Over half of patients with metastatic melanoma do not meet eligibility criteria for participation in phase III clinical trials of immunothe… Continue reading
Genetic Literacy Project |
Why CRISPR, other academia-produced technologies, should belong to everyone
Genetic Literacy Project [According to Michael Eisen, Berkeley professor and co-founder of the Public Library of Science] intellectual property in academia is a drain on the system. It’s a model that was ushered in decades ago with an aim to encourage innovation. Instead, it … |
Genetic Literacy Project |
Why CRISPR, other academia-produced technologies, should belong to everyone
Genetic Literacy Project [According to Michael Eisen, Berkeley professor and co-founder of the Public Library of Science] intellectual property in academia is a drain on the system. It’s a model that was ushered in decades ago with an aim to encourage innovation. Instead, it … |
|
Immunotherapy Trials in Head and Neck Cancer
Cancer Network In this video, Barbara Burtness, MD, of the Yale Cancer Center and Smilow Cancer Hospital in New Haven, Connecticut, discusses two ongoing trials testing immunotherapy in different settings for patients with head and neck cancer. The first, a phase III … Cancer Immunotherapy Market Key Trends & Industry Forecast 2016 – 2024Medgadget (blog) |
|
Immunotherapy Trials in Head and Neck Cancer
Cancer Network In this video, Barbara Burtness, MD, of the Yale Cancer Center and Smilow Cancer Hospital in New Haven, Connecticut, discusses two ongoing trials testing immunotherapy in different settings for patients with head and neck cancer. The first, a phase III … Cancer Immunotherapy Market Key Trends & Industry Forecast 2016 – 2024Medgadget (blog) |